Nuevocor presents pre-clinical data at ESGCT and AHA meetings
- Written by PR Newswire
SINGAPORE, Nov. 7, 2023 /PRNewswire/ -- Nuevocor, a pre-clinical stage biotechnology company focused on developing cardiac genetic medicines through a unique platform to understand the mechanobiological causes of disease, announced today a pair of presentations at two major meetings, the European Society for Gene and Cell Therapy (ESGCT) 30th Annua...
Read more: Nuevocor presents pre-clinical data at ESGCT and AHA meetings














